Neuropeptide Y inhibits capsaicin-sensitive nociceptors via a Y1-receptor-mediated mechanism

Jennifer Gibbs, C. M. Flores, K. M. Hargreaves

Research output: Contribution to journalArticle

Abstract

Neuropeptide Y (NPY) is expressed in certain primary afferent fibers, is up-regulated in response to tissue injury and is capable of inhibiting nociceptive behavior at the spinal level. However, the spinal mechanism(s) for NPY-evoked antinociception is unknown. In this study, we evaluated the hypothesis that agonists at the NPY Y1 receptor subtype (Y1-R) inhibit exocytosis from the capsaicin-sensitive class of nociceptors. Using in vitro superfusion of rat dorsal spinal cord slices, pre-treatment with the Y1-R agonist [Leu31Pro34]NPY significantly inhibited capsaicin-evoked release of immunoreactive calcitonin gene-related peptide with an EC50 value of 10.6 nM. This inhibitory effect was concentration dependent, significantly attenuated by pre-treatment with the Y1 receptor antagonist BIBP3226 and reproduced by synthetic NPY. Examination of adult rat dorsal root ganglia using double immunofluorescent labeling revealed frequent co-localization of Y1 receptor immunoreactivity in vanilloid receptor type 1-immunoreactive neurons, indicating that Y1 agonists may directly modulate the capsaicin-sensitive class of nociceptors. Collectively, these results indicate that NPY is capable of inhibiting capsaicin-sensitive neurons via a Y1 receptor mechanism, suggesting the mechanisms for spinal NPY-induced antinociception is due, at least in part, to inhibition of central terminals of capsaicin-sensitive nociceptors.

Original languageEnglish (US)
Pages (from-to)703-709
Number of pages7
JournalNeuroscience
Volume125
Issue number3
DOIs
StatePublished - 2004

Fingerprint

Nociceptors
Capsaicin
Neuropeptide Y
Neurons
Calcitonin Gene-Related Peptide
Exocytosis
Spinal Ganglia
Spinal Cord
Wounds and Injuries
Therapeutics

Keywords

  • Analysis of variance
  • ANOVA
  • Calcitonin gene-related peptide
  • CGRP
  • Dorsal root ganglion
  • DRG
  • Exocytosis
  • iCGRP
  • Immunoreactive calcitonin gene-related peptide
  • Neuropeptide Y
  • NGS
  • Normal goat serum
  • NPY
  • Pain
  • SP
  • Spinal cord
  • Superfusion

ASJC Scopus subject areas

  • Neuroscience(all)

Cite this

Neuropeptide Y inhibits capsaicin-sensitive nociceptors via a Y1-receptor-mediated mechanism. / Gibbs, Jennifer; Flores, C. M.; Hargreaves, K. M.

In: Neuroscience, Vol. 125, No. 3, 2004, p. 703-709.

Research output: Contribution to journalArticle

Gibbs, Jennifer ; Flores, C. M. ; Hargreaves, K. M. / Neuropeptide Y inhibits capsaicin-sensitive nociceptors via a Y1-receptor-mediated mechanism. In: Neuroscience. 2004 ; Vol. 125, No. 3. pp. 703-709.
@article{6f6a9061f308406eb959139967f7d2c6,
title = "Neuropeptide Y inhibits capsaicin-sensitive nociceptors via a Y1-receptor-mediated mechanism",
abstract = "Neuropeptide Y (NPY) is expressed in certain primary afferent fibers, is up-regulated in response to tissue injury and is capable of inhibiting nociceptive behavior at the spinal level. However, the spinal mechanism(s) for NPY-evoked antinociception is unknown. In this study, we evaluated the hypothesis that agonists at the NPY Y1 receptor subtype (Y1-R) inhibit exocytosis from the capsaicin-sensitive class of nociceptors. Using in vitro superfusion of rat dorsal spinal cord slices, pre-treatment with the Y1-R agonist [Leu31Pro34]NPY significantly inhibited capsaicin-evoked release of immunoreactive calcitonin gene-related peptide with an EC50 value of 10.6 nM. This inhibitory effect was concentration dependent, significantly attenuated by pre-treatment with the Y1 receptor antagonist BIBP3226 and reproduced by synthetic NPY. Examination of adult rat dorsal root ganglia using double immunofluorescent labeling revealed frequent co-localization of Y1 receptor immunoreactivity in vanilloid receptor type 1-immunoreactive neurons, indicating that Y1 agonists may directly modulate the capsaicin-sensitive class of nociceptors. Collectively, these results indicate that NPY is capable of inhibiting capsaicin-sensitive neurons via a Y1 receptor mechanism, suggesting the mechanisms for spinal NPY-induced antinociception is due, at least in part, to inhibition of central terminals of capsaicin-sensitive nociceptors.",
keywords = "Analysis of variance, ANOVA, Calcitonin gene-related peptide, CGRP, Dorsal root ganglion, DRG, Exocytosis, iCGRP, Immunoreactive calcitonin gene-related peptide, Neuropeptide Y, NGS, Normal goat serum, NPY, Pain, SP, Spinal cord, Superfusion",
author = "Jennifer Gibbs and Flores, {C. M.} and Hargreaves, {K. M.}",
year = "2004",
doi = "10.1016/j.neuroscience.2004.01.044",
language = "English (US)",
volume = "125",
pages = "703--709",
journal = "Neuroscience",
issn = "0306-4522",
publisher = "Elsevier Limited",
number = "3",

}

TY - JOUR

T1 - Neuropeptide Y inhibits capsaicin-sensitive nociceptors via a Y1-receptor-mediated mechanism

AU - Gibbs, Jennifer

AU - Flores, C. M.

AU - Hargreaves, K. M.

PY - 2004

Y1 - 2004

N2 - Neuropeptide Y (NPY) is expressed in certain primary afferent fibers, is up-regulated in response to tissue injury and is capable of inhibiting nociceptive behavior at the spinal level. However, the spinal mechanism(s) for NPY-evoked antinociception is unknown. In this study, we evaluated the hypothesis that agonists at the NPY Y1 receptor subtype (Y1-R) inhibit exocytosis from the capsaicin-sensitive class of nociceptors. Using in vitro superfusion of rat dorsal spinal cord slices, pre-treatment with the Y1-R agonist [Leu31Pro34]NPY significantly inhibited capsaicin-evoked release of immunoreactive calcitonin gene-related peptide with an EC50 value of 10.6 nM. This inhibitory effect was concentration dependent, significantly attenuated by pre-treatment with the Y1 receptor antagonist BIBP3226 and reproduced by synthetic NPY. Examination of adult rat dorsal root ganglia using double immunofluorescent labeling revealed frequent co-localization of Y1 receptor immunoreactivity in vanilloid receptor type 1-immunoreactive neurons, indicating that Y1 agonists may directly modulate the capsaicin-sensitive class of nociceptors. Collectively, these results indicate that NPY is capable of inhibiting capsaicin-sensitive neurons via a Y1 receptor mechanism, suggesting the mechanisms for spinal NPY-induced antinociception is due, at least in part, to inhibition of central terminals of capsaicin-sensitive nociceptors.

AB - Neuropeptide Y (NPY) is expressed in certain primary afferent fibers, is up-regulated in response to tissue injury and is capable of inhibiting nociceptive behavior at the spinal level. However, the spinal mechanism(s) for NPY-evoked antinociception is unknown. In this study, we evaluated the hypothesis that agonists at the NPY Y1 receptor subtype (Y1-R) inhibit exocytosis from the capsaicin-sensitive class of nociceptors. Using in vitro superfusion of rat dorsal spinal cord slices, pre-treatment with the Y1-R agonist [Leu31Pro34]NPY significantly inhibited capsaicin-evoked release of immunoreactive calcitonin gene-related peptide with an EC50 value of 10.6 nM. This inhibitory effect was concentration dependent, significantly attenuated by pre-treatment with the Y1 receptor antagonist BIBP3226 and reproduced by synthetic NPY. Examination of adult rat dorsal root ganglia using double immunofluorescent labeling revealed frequent co-localization of Y1 receptor immunoreactivity in vanilloid receptor type 1-immunoreactive neurons, indicating that Y1 agonists may directly modulate the capsaicin-sensitive class of nociceptors. Collectively, these results indicate that NPY is capable of inhibiting capsaicin-sensitive neurons via a Y1 receptor mechanism, suggesting the mechanisms for spinal NPY-induced antinociception is due, at least in part, to inhibition of central terminals of capsaicin-sensitive nociceptors.

KW - Analysis of variance

KW - ANOVA

KW - Calcitonin gene-related peptide

KW - CGRP

KW - Dorsal root ganglion

KW - DRG

KW - Exocytosis

KW - iCGRP

KW - Immunoreactive calcitonin gene-related peptide

KW - Neuropeptide Y

KW - NGS

KW - Normal goat serum

KW - NPY

KW - Pain

KW - SP

KW - Spinal cord

KW - Superfusion

UR - http://www.scopus.com/inward/record.url?scp=1942424825&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=1942424825&partnerID=8YFLogxK

U2 - 10.1016/j.neuroscience.2004.01.044

DO - 10.1016/j.neuroscience.2004.01.044

M3 - Article

C2 - 15099684

AN - SCOPUS:1942424825

VL - 125

SP - 703

EP - 709

JO - Neuroscience

JF - Neuroscience

SN - 0306-4522

IS - 3

ER -